Table 1

Baseline characteristics of the study population (n = 202)

Total sample

Female

Male

gender comparisons


Total sample (n [%])

202 (100)

124 (61.4)

78 (38.6)


Age (mean [SD])

49.7 (13.5)

50.2 (13.2)

48.9 (14.1)

n.s.1


Groups of diagnoses (n [%])


UPVD

77 (38.1)

46 (37.1)

31 (39.7)

n.s.2


BPVD

18 (8.9)

9 (7.3)

9 (11.5)


Psychophysic dizziness

20 (9.9)

14 (11.3)

6 (7.7)


Vestibular migraine

27 (13.4)

19 (15.3)

8 (10.3)


Multiple vestibular disorders

16 (7.9)

11 (8.9)

5 (6.4)


CVD

19 (9.4)

10 (8.1)

9 (11.5)


Multifactorial dizziness

25 (12.4)

15 (12.1)

10 (12.8)


Illness duration (n [%])


> 1 mo, < 6 mo

58 (28.7)

37 (29.8)

21 (26.9)

n.s.2


> 6 mo, < 12 mo

27 (13.4)

15 (12.1)

12 (15.4)


> 12 mo

117 (57.9)

72 (58.1)

45 (57.7)


Employment status (n [%])


not employed

61 (30.2)

43 (34.7)

18 (23.1)

p2 = 0.000


< 50%

23 (11.4)

17 (13.7)

6 (7.7)


50 - 79%

25 (12.4)

23 (18.5)

2 (2.6)


> 80%

93 (46.0)

41 (33.1)

52 (66.7)


Living condition (n [%])


alone

39 (19.3)

20 (16.1)

19 (24.4)

n.s.2


with adult partner

97 (48.0)

61 (49.2)

36 (46.2)


with adult partner and childs

57 (28.2)

34 (27.4)

23 (29.5)


with childs

9 (4.5)

9 (7.3)

0


DHI-G (mean [SD])

44.6 (22.2)

45.8 (21.7)

42.6 (23.0)

n.s.1


HADS-A* (median [IQR])

6.0 (6.0)

6.0 (6.0)

6.0 (7.0)

n.s.3


HADS-D* (median [IQR])

4.0 (5.0)

4.0 (5.0)

4.0 (7.0)

n.s.3


VSS-VER (median [IQR])

17.0 (18.0)

17.0 (18.0)

14.5 (16.0)

n.s.3


VSS-AA (median [IQR])

17.0 (15.0)

18.0 (15.0)

14.0 (12.75)

n.s.3



* n = 200

1 = Student t-test

2 = Pearson chi-square statistic

3 = Mann-Whitney U

BPVD indicates bilateral peripheral vestibular dysfunction, CVD central vestibular dysfunction, HADS Hospital Anxiety and Depression Scale, HADS-A anxiety subscale of the HADS (score: 0-21), HADS-D depression subscale of the HADS (score: 0-21), mo month, n.s. not significant, UPVD unilateral peripheral vestibular dysfunction, VSS Vertigo Symptom Scale, VSS-VER subscale measuring 'vertigo and related symptoms' (Score: 0-76), VSS-AA subscale measuring 'somatic anxiety and autonomic arousal' (Score: 0-60).

Kurre et al. BMC Ear, Nose and Throat Disorders 2012 12:2   doi:10.1186/1472-6815-12-2

Open Data